BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 37598759)

  • 1. Caenorhabditis elegans: A transgenic model for studying age-associated neurodegenerative diseases.
    Rani N; Alam MM; Jamal A; Bin Ghaffar U; Parvez S
    Ageing Res Rev; 2023 Nov; 91():102036. PubMed ID: 37598759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modeling neurodegenerative diseases in Caenorhabditis elegans.
    Li J; Le W
    Exp Neurol; 2013 Dec; 250():94-103. PubMed ID: 24095843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Towards Understanding Neurodegenerative Diseases: Insights from
    Wu Y; Chen Y; Yu X; Zhang M; Li Z
    Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modeling human neurodegenerative diseases in transgenic systems.
    Gama Sosa MA; De Gasperi R; Elder GA
    Hum Genet; 2012 Apr; 131(4):535-63. PubMed ID: 22167414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Caenorhabditis elegans as an experimental tool for the study of complex neurological diseases: Parkinson's disease, Alzheimer's disease and autism spectrum disorder.
    Calahorro F; Ruiz-Rubio M
    Invert Neurosci; 2011 Dec; 11(2):73-83. PubMed ID: 22068627
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Van Pelt KM; Truttmann MC
    Transl Med Aging; 2020; 4():60-72. PubMed ID: 34327290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interplay of RNA-Binding Proteins and microRNAs in Neurodegenerative Diseases.
    Kinoshita C; Kubota N; Aoyama K
    Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34069857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of connexins in neurodegenerative diseases (Review).
    Xing J; Xu C
    Mol Med Rep; 2021 May; 23(5):. PubMed ID: 33760195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting stress granules in neurodegenerative diseases: A focus on biological function and dynamics disorders.
    Fang M; Liu Y; Huang C; Fan S
    Biofactors; 2024; 50(3):422-438. PubMed ID: 37966813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. lncRNA NEAT1: Key player in neurodegenerative diseases.
    Li K; Wang Z
    Ageing Res Rev; 2023 Apr; 86():101878. PubMed ID: 36738893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insights from Caenorhabditis elegans on the role of metals in neurodegenerative diseases.
    Martinez-Finley EJ; Avila DS; Chakraborty S; Aschner M
    Metallomics; 2011 Mar; 3(3):271-9. PubMed ID: 21210060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transgenic animal models of neurodegenerative diseases and their application to treatment development.
    Rockenstein E; Crews L; Masliah E
    Adv Drug Deliv Rev; 2007 Sep; 59(11):1093-102. PubMed ID: 17869376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A Nematode Nobel Prize: Caenorhabditis elegans].
    Savel J; Clostre F
    Ann Pharm Fr; 2006 Sep; 64(5):291-307. PubMed ID: 17095949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic neurodegenerative diseases: the human illness and transgenic models.
    Price DL; Sisodia SS; Borchelt DR
    Science; 1998 Nov; 282(5391):1079-83. PubMed ID: 9804539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transgenic invertebrate models of age-associated neurodegenerative diseases.
    Link CD
    Mech Ageing Dev; 2001 Sep; 122(14):1639-49. PubMed ID: 11511401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unraveling Molecular and Genetic Insights into Neurodegenerative Diseases: Advances in Understanding Alzheimer's, Parkinson's, and Huntington's Diseases and Amyotrophic Lateral Sclerosis.
    Ciurea AV; Mohan AG; Covache-Busuioc RA; Costin HP; Glavan LA; Corlatescu AD; Saceleanu VM
    Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37445986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transgenic animal models of neurodegeneration based on human genetic studies.
    Harvey BK; Richie CT; Hoffer BJ; Airavaara M
    J Neural Transm (Vienna); 2011 Jan; 118(1):27-45. PubMed ID: 20931247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Caenorhabditis elegans as a model system for target identification and drug screening against neurodegenerative diseases.
    Ma L; Zhao Y; Chen Y; Cheng B; Peng A; Huang K
    Eur J Pharmacol; 2018 Jan; 819():169-180. PubMed ID: 29208474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Using C. elegans as a model for neurodegenerative diseases: Methodology and evaluation.
    Caldero-Escudero E; Romero-Sanz S; De la Fuente S
    Methods Cell Biol; 2024; 188():1-34. PubMed ID: 38880519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathways to healing: Plants with therapeutic potential for neurodegenerative diseases.
    Tyler SEB; Tyler LDK
    IBRO Neurosci Rep; 2023 Jun; 14():210-234. PubMed ID: 36880056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.